StonvexLoading…
StonvexStonvexStonvexCore line items from NTRA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.31B | $1.70B | $1.08B | $820.22M |
Operating Income | $-309.91M | $-222.29M | $-446.25M | $-541.04M |
Net Income | $-208.16M | $-190.43M | $-434.80M | $-547.80M |
EPS (Diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 |
Total Assets | $2.40B | $1.66B | $1.44B | $1.39B |
Total Liabilities | $685.93M | $465.31M | $676.37M | $688.73M |
Cash & Equivalents | $1.08B | $945.59M | $642.10M | $466.00M |
Free Cash Flow OCF − CapEx | $109.11M | $69.24M | $-286.15M | $-479.20M |
Shares Outstanding | 139.69M | 132.65M | 119.58M | 111.25M |